生长激素激发试验和胰岛素样生长因子1水平检测对生长激素缺乏症的诊断意义和思考

李堂

doi:10.7499/j.issn.1008-8830.2308076

PDF(507 KB)

HTML

中国当代儿科杂志 ›› 2023, Vol. 25 ›› Issue (12) : 1193-1197. DOI: 10.7499/j.issn.1008-8830.2308076

系列讲座——儿童矮身材的规范诊疗

生长激素激发试验和胰岛素样生长因子1水平检测对生长激素缺乏症的诊断意义和思考

李堂

作者信息 +

Diagnostic significance and considerations of growth hormone stimulation testing and insulin-like growth factor 1 in growth hormone deficiency

LI Tang

Author information +

文章历史 +

摘要

生长激素（growth hormone, GH）/胰岛素样生长因子1（insulin growth factor-1, IGF-1）轴是下丘脑/垂体生长激素轴的重要组成部分，对儿童生长发育具有关键性作用。GH/IGF-1轴信号通路及其旁路的紊乱和异常通常在儿童时期表现为身材矮小。身材矮小的儿童通常需进行GH激发试验及IGF-1水平检测，以鉴别生长激素缺乏症（growth hormone deficiency, GHD）和其他导致生长迟缓的原因。该文对GH激发试验和IGF-1检测值进行分析与阐述，以期为临床儿童GHD的诊断提供参考。

Abstract

The growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis is an essential component of the hypothalamic-pituitary growth hormone axis and plays a crucial role in childhood growth and development. Disruptions and abnormalities in the GH/IGF-1 signaling pathway and its pathways typically manifest as short stature in children. Children with short stature often undergo GH stimulation testing and IGF-1 level measurements to differentiate growth hormone deficiency (GHD) from other causes of growth delay. This article aims to analyze and elucidate the values of GH stimulation testing and IGF-1 measurement, providing reference for the diagnosis of GHD in children.

导出引用

李堂. 生长激素激发试验和胰岛素样生长因子1水平检测对生长激素缺乏症的诊断意义和思考[J]. 中国当代儿科杂志. 2023, 25(12): 1193-1197 https://doi.org/10.7499/j.issn.1008-8830.2308076

LI Tang. Diagnostic significance and considerations of growth hormone stimulation testing and insulin-like growth factor 1 in growth hormone deficiency[J]. Chinese Journal of Contemporary Pediatrics. 2023, 25(12): 1193-1197 https://doi.org/10.7499/j.issn.1008-8830.2308076

参考文献

1 Ranke MB, Wit JM. Growth hormone: past, present and future[J]. Nat Rev Endocrinol, 2018, 14(5): 285-300. PMID: 29546874. DOI: 10.1038/nrendo.2018.22.
2 程昕然, 冷洁. GH-IGF-I轴信号通路及旁分泌信号通路生长障碍发生机制[J]. 中国实用儿科杂志, 2021, 36(8): 592-597. DOI: 10.19538/j.ek2021080607.
3 Locatelli V, Bianchi VE. Effect of GH/IGF-1 on bone metabolism and osteoporsosis[J]. Int J Endocrinol, 2014, 2014: 235060. PMID: 25147565. PMCID: PMC4132406. DOI: 10.1155/2014/235060.
4 Sodero G, Mariani F, Caprarelli M, et al. Growth hormone responses during arginine and clonidine stimulation test: correlations with patients' auxological and metabolic parameters in a single centre study[J]. Growth Horm IGF Res, 2023, 68: 101522. PMID: 36502626. DOI: 10.1016/j.ghir.2022.101522.
5 Kamoun C, Hawkes CP, Grimberg A. Provocative growth hormone testing in children: how did we get here and where do we go now?[J]. J Pediatr Endocrinol Metab, 2021, 34(6): 679-696. PMID: 33838090. PMCID: PMC8165022. DOI: 10.1515/jpem-2021-0045.
6 中华医学会儿科学分会内分泌遗传代谢学组. 矮身材儿童诊治指南[J]. 中华儿科杂志, 2008, 46(6): 428-430. PMID: 19099778. DOI: 10.3321/j.issn:0578-1310.2008.06.007.
7 Bright GM, Morris PA, Rosenfeld RG. When is a positive test for pediatric growth hormone deficiency a true-positive test?[J]. Horm Res Paediatr, 2021, 94(11-12): 399-405. PMID: 34856538. DOI: 10.1159/000521281.
8 Shen Y, Zhang J, Zhao Y, et al. Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis[J]. Eur J Pediatr, 2015, 174(4): 419-427. PMID: 25213432. DOI: 10.1007/s00431-014-2406-3.
9 中华人民共和国国家卫生健康委员会医政医管局. 国家卫生健康委办公厅关于印发有关病种临床路径（2019年版）的通知：国卫办医函[2019] 933号[EB/OL]. (2020-01-02)[2023-03-28]. http://www.nhc.gov.cn/yzygj/s7659/202001/b3c9e097b0c1471a969d7a63be471759.shtml.
10 中华医学会儿科学分会内分泌遗传代谢学组, 《中华儿科杂志》编辑委员会, 梁雁. 基因重组人生长激素儿科临床规范应用的建议[J]. 中华儿科杂志, 2013, 51(6): 426-432. PMID: 24120059. DOI: 10.3760/cma.j.issn.0578-1310.2013.06.007.
11 Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children[J]. J Clin Endocrinol Metab, 1996, 81(9): 3323-3327. PMID: 8784091. DOI: 10.1210/jcem.81.9.8784091.
12 Oron T, Krieger A, Yakobovich-Gavan M, et al. Diagnosing growth hormone deficiency: can a combined arginine and clonidine stimulation test replace 2 separate tests?[J]. Endocr Pract, 2022, 28(1): 36-43. PMID: 34418530. DOI: 10.1016/j.eprac.2021.08.004.
13 Collett-Solberg PF, Ambler G, Backeljauw PF, et al. Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective[J]. Horm Res Paediatr, 2019, 92(1): 1-14. PMID: 31514194. PMCID: PMC6979443. DOI: 10.1159/000502231.
14 Yau M, Rapaport R. Growth hormone stimulation testing: to test or not to test? That is one of the questions[J]. Front Endocrinol (Lausanne), 2022, 13: 902364. PMID: 35757429. PMCID: PMC9218712. DOI: 10.3389/fendo.2022.902364.
15 Abawi O, Augustijn D, Hoeks SE, et al. Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis[J]. Crit Rev Clin Lab Sci, 2021, 58(8): 576-595. PMID: 34431447. DOI: 10.1080/10408363.2021.1956423.
16 Thieme F, Vogel M, Gausche R, et al. The influence of body mass index on the growth hormone peak response regarding growth hormone stimulation tests in children[J]. Horm Res Paediatr, 2022, 95(5): 452-460. PMID: 35908538. DOI: 10.1159/000526240.
17 Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency[J]. Horm Res Paediatr, 2016, 86(6): 361-397. PMID: 27884013. DOI: 10.1159/000452150.
18 Hage C, Gan HW, Ibba A, et al. Advances in differential diagnosis and management of growth hormone deficiency in children[J]. Nat Rev Endocrinol, 2021, 17(10): 608-624. PMID: 34417587. DOI: 10.1038/s41574-021-00539-5.
19 Chen J, Wang X, He C, et al. MRI findings of pituitary gland in growth hormone-deficient children and their correlation with growth hormone peak during growth hormone stimulation tests[J]. Contrast Media Mol Imaging, 2022, 2022: 3111585. PMID: 36003997. PMCID: PMC9385284. DOI: 10.1155/2022/3111585.
20 Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society[J]. J Clin Endocrinol Metab. 2000,85(11):3990-3993. PMID: 11095419. DOI: 10.1210/jcem.85.11.6984.
21 Binder G, Weber K, Rieflin N, et al. Diagnosis of severe growth hormone deficiency in the newborn[J]. Clin Endocrinol (Oxf), 2020, 93(3): 305-311. PMID: 32521075. DOI: 10.1111/cen.14264.
22 Yau M, Chacko E, Regelmann MO, et al. Peak growth hormone response to combined stimulation test in 315 children and correlations with metabolic parameters[J]. Horm Res Paediatr, 2019, 92(1): 36-44. PMID: 31461713. DOI: 10.1159/000502308.
23 Collett-Solberg PF, Jorge AAL, Boguszewski MCS, et al. Growth hormone therapy in children; research and practice: a review[J]. Growth Horm IGF Res, 2019, 44: 20-32. PMID: 30605792. DOI: 10.1016/j.ghir.2018.12.004.
24 许珊珊, 顾学范, 潘慧, 等. 儿童青少年血清胰岛素生长因子-1及胰岛素因子结合蛋白-3的正常参考值研究[J]. 临床儿科杂志, 2009, 27(12): 1105-1110. DOI: 10.3969/j.issn.1000-3606.2009.12.002.
25 Cao B, Peng Y, Song W, et al. Pediatric continuous reference intervals of serum insulin-like growth factor 1 levels in a healthy Chinese children population-based on PRINCE study[J]. Endocr Pract, 2022, 28(7): 696-702. PMID: 35430364. DOI: 10.1016/j.eprac.2022.04.004.
26 Kim JH, Chae HW, Chin SO, et al. Diagnosis and treatment of growth hormone deficiency: a position statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology[J]. Endocrinol Metab (Seoul), 2020, 35(2): 272-287. PMID: 32615711. PMCID: PMC7386113. DOI: 10.3803/EnM.2020.35.2.272.
27 Allen DB, Cuttler L. Clinical practice. Short stature in childhood--challenges and choices[J]. N Engl J Med, 2013, 368(13): 1220-1228. PMID: 23534561. PMCID: PMC5754004. DOI: 10.1056/NEJMcp1213178.
28 Iwayama H, Kitagawa S, Sada J, et al. Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency[J]. Sci Rep, 2021, 11(1): 16159. PMID: 34373538. PMCID: PMC8352887. DOI: 10.1038/s41598-021-95632-0.
29 Bibi A, Aamir M, Haroon ZH, et al. Etiological study of short stature in children and role of insulin like growth factor-1 and insulin like growth factor binding protein-3 as screening markers for growth hormone deficiency[J]. J Pak Med Assoc, 2023, 73(2): 323-327. PMID: 36800719. DOI: 10.47391/JPMA.6430.
30 Inoue-Lima TH, Vasques GA, Nakaguma M, et al. A Bayesian approach to diagnose growth hormone deficiency in children: insulin-like growth factor type 1 is valuable for screening and IGF-binding protein type 3 for confirmation[J]. Horm Res Paediatr, 2020, 93(3): 197-205. PMID: 32799208. DOI: 10.1159/000509840.
31 Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop[J]. J Clin Endocrinol Metab, 2008, 93(11): 4210-4217. PMID: 18782877. DOI: 10.1210/jc.2008-0509.
32 Wit JM, Kamp GA, Oostdijk W, et al. Towards a rational and efficient diagnostic approach in children referred for growth failure to the general paediatrician[J]. Horm Res Paediatr, 2019, 91(4): 223-240. PMID: 31195397. DOI: 10.1159/000499915.
33 Wit JM, Bidlingmaier M, de Bruin C, et al. A proposal for the interpretation of serum IGF-I concentration as part of laboratory screening in children with growth failure[J]. J Clin Res Pediatr Endocrinol, 2020, 12(2): 130-139. PMID: 31842524. PMCID: PMC7291410. DOI: 10.4274/jcrpe.galenos.2019.2019.0176.